Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$119.98 - $132.61 $3.45 Million - $3.81 Million
-28,732 Reduced 93.89%
1,869 $246,000
Q4 2023

Feb 09, 2024

SELL
$102.72 - $121.7 $4.43 Million - $5.24 Million
-43,088 Reduced 58.47%
30,601 $3.72 Million
Q3 2023

Nov 02, 2023

BUY
$110.76 - $143.18 $699,781 - $904,611
6,318 Added 9.38%
73,689 $8.27 Million
Q2 2023

Aug 08, 2023

BUY
$126.43 - $145.6 $4.47 Million - $5.14 Million
35,323 Added 110.22%
67,371 $9.81 Million
Q1 2023

May 01, 2023

SELL
$121.91 - $130.94 $125,567 - $134,868
-1,030 Reduced 3.11%
32,048 $4.14 Million
Q4 2022

Feb 08, 2023

SELL
$104.7 - $128.4 $1.12 Million - $1.37 Million
-10,696 Reduced 24.43%
33,078 $0
Q3 2022

Nov 10, 2022

SELL
$101.65 - $119.27 $73,899 - $86,709
-727 Reduced 1.63%
43,774 $4.58 Billion
Q2 2022

Aug 05, 2022

BUY
$102.23 - $133.85 $48,252 - $63,177
472 Added 1.07%
44,501 $4.68 Million
Q1 2022

May 04, 2022

BUY
$108.42 - $129.58 $102,565 - $122,582
946 Added 2.2%
44,029 $5.63 Million
Q4 2021

Feb 02, 2022

BUY
$115.43 - $146.63 $1.36 Million - $1.72 Million
11,764 Added 37.56%
43,083 $5.47 Million
Q3 2021

Nov 10, 2021

BUY
$136.35 - $158.76 $320,831 - $373,562
2,353 Added 8.12%
31,319 $4.58 Million
Q2 2021

Aug 11, 2021

BUY
$152.95 - $173.41 $139,184 - $157,803
910 Added 3.24%
28,966 $4.66 Million
Q1 2021

May 10, 2021

BUY
$148.16 - $159.71 $792,952 - $854,767
5,352 Added 23.57%
28,056 $4.49 Million
Q4 2020

Feb 11, 2021

BUY
$128.25 - $151.41 $282,278 - $333,253
2,201 Added 10.74%
22,704 $3.5 Million
Q3 2020

Nov 10, 2020

BUY
$113.59 - $141.68 $768,549 - $958,606
6,766 Added 49.25%
20,503 $2.79 Million
Q2 2020

Aug 13, 2020

BUY
$87.02 - $133.4 $1.2 Million - $1.83 Million
13,737 New
13,737 $1.64 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.2B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Pictet & Cie (Europe) Sa Portfolio

Follow Pictet & Cie (Europe) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.